Literature DB >> 8949594

Severe pulmonary dysfunction following acute respiratory distress syndrome.

H R Smith1, D G Sinclair.   

Abstract

Recovery of lung function following the acute respiratory distress syndrome (ARDS) is thought to be related to the severity of the initial insult. We report a case demonstrating virtually complete functional recovery following severe ARDS. The significance of this and the need for comprehensive follow-up of such patients is discussed.

Entities:  

Mesh：

Year:  1996        PMID： 8949594      PMCID： PMC2398557          DOI： 10.1136/pgmj.72.851.555

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


  6 in total

Review 1.  The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination.

Authors:  G R Bernard; A Artigas; K L Brigham; J Carlet; K Falke; L Hudson; M Lamy; J R Legall; A Morris; R Spragg
Journal:  Am J Respir Crit Care Med       Date:  1994-03       Impact factor: 21.405

2.  Clinical determinants of abnormalities in pulmonary functions in survivors of the adult respiratory distress syndrome.

Authors:  J I Peters; R C Bell; T J Prihoda; G Harris; C Andrews; W G Johanson
Journal:  Am Rev Respir Dis       Date:  1989-05

3.  Pulmonary function following severe acute respiratory failure and high levels of positive end-expiratory pressure.

Authors:  M E Douglas; J B Downs
Journal:  Chest       Date:  1977-01       Impact factor: 9.410

4.  Prediction of pulmonary function abnormalities after adult respiratory distress syndrome (ARDS).

Authors:  C G Elliott; B Y Rasmusson; R O Crapo; A H Morris; R L Jensen
Journal:  Am Rev Respir Dis       Date:  1987-03

5.  Sequelae of the adult respiratory distress syndrome.

Authors:  R Hert; R K Albert
Journal:  Thorax       Date:  1994-01       Impact factor: 9.139

6.  Pulmonary function following the adult respiratory distress syndrome.

Authors:  J Yahav; P Lieberman; M Molho
Journal:  Chest       Date:  1978-09       Impact factor: 9.410
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.